NasdaqGM - Nasdaq Real Time Price USD
Verona Pharma plc (VRNA)
As of 11:26 AM EST. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 4,450,000 | 7 |
Sales | 2,203,528 | 6 |
Net Shares Purchased (Sold) | 2,246,472 | 13 |
Total Insider Shares Held | 14.12M | -- |
% Net Shares Purchased (Sold) | 18.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
HAHN MARK W Chief Financial Officer | Sale at price 34.98 - 38.15 per share. | Direct | 4,792,012 | Nov 4, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 34.98 - 38.15 per share. | Direct | 5,231,736 | Nov 4, 2024 |
HAHN MARK W Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 1, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 1, 2024 |
RICKARD KATHLEEN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 1, 2024 |
FISHER ANDREW General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 30, 2024 |
HAHN MARK W Chief Financial Officer | Sale at price 33.86 - 34.43 per share. | Direct | 4,975,377 | Oct 25, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 33.86 - 34.93 per share. | Direct | 4,983,287 | Oct 25, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 34.63 - 34.97 per share. | Direct | 17,896,329 | Oct 22, 2024 |
HAHN MARK W Chief Financial Officer | Sale at price 30.15 per share. | Direct | 18,090,000 | Sep 11, 2024 |
HAHN MARK W Chief Financial Officer | Sale at price 24.68 - 26.73 per share. | Direct | 10,688,720 | Aug 13, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 24.68 - 26.73 per share. | Direct | 10,688,720 | Aug 13, 2024 |
HAHN MARK W Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 7, 2024 |
ZACCARDELLI DAVID S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 7, 2024 |
RICKARD KATHLEEN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 7, 2024 |
RICKARD KATHLEEN A Officer | Sale at price 15.69 per share. | Direct | 568,731 | May 3, 2024 |
RICKARD KATHLEEN A Officer | Sale at price 18.31 per share. | Direct | 663,701 | Feb 5, 2024 |
POLL CLAIRE LOUISE General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 1, 2024 |
EDWARDS MARTIN Director | Purchase at price 14.73 per share. | Direct | 496,931 | Nov 20, 2023 |
EBSWORTH DAVID R Director | Purchase at price 15.12 per share. | Direct | 2,419,200 | Nov 6, 2023 |
RICKARD KATHLEEN A Officer | Sale at price 15.37 per share. | Direct | 903,018 | Nov 3, 2023 |
HAHN MARK W Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
ZACCARDELLI DAVID S Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
RICKARD KATHLEEN A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
POLL CLAIRE LOUISE General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 20, 2023 |
HAHN MARK W Chief Financial Officer | Sale at price 19.04 - 20.04 per share. | Direct | 5,503,680 | Aug 7, 2023 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 19.04 - 20.04 per share. | Direct | 5,503,680 | Aug 7, 2023 |
RICKARD KATHLEEN A Officer | Sale at price 19.04 - 20.04 per share. | Direct | 1,601,412 | Aug 7, 2023 |
POLL CLAIRE LOUISE General Counsel | Sale at price 19.04 - 20.04 per share. | Direct | 966,968 | Aug 7, 2023 |
POLL CLAIRE LOUISE General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 7, 2023 |
HAHN MARK W Chief Financial Officer | Sale at price 20.64 - 21.45 per share. | Direct | 3,793,381 | Aug 2, 2023 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 20.64 - 21.45 per share. | Direct | 3,793,381 | Aug 2, 2023 |
RICKARD KATHLEEN A Officer | Sale at price 20.64 - 21.45 per share. | Direct | 706,614 | Aug 2, 2023 |
POLL CLAIRE LOUISE General Counsel | Sale at price 20.64 - 21.45 per share. | Direct | 666,241 | Aug 2, 2023 |
GUPTA RISHI Director | Sale at price 20.00 - 22.26 per share. | Indirect | 9,938,132 | May 15, 2023 |
ORBIMED ADVISORS, L.L.C. Unknown | Sale at price 20.00 - 22.26 per share. | Indirect | 9,938,132 | May 15, 2023 |
RICKARD KATHLEEN A Officer | Sale at price 20.72 - 21.19 per share. | Direct | 2,213,480 | May 3, 2023 |
RICKARD KATHLEEN A Officer | Sale at price 20.72 - 21.19 per share. | Direct | 2,213,480 | May 3, 2023 |
RICKARD KATHLEEN A Officer | -- | Direct | -- | May 1, 2023 |
POLL CLAIRE LOUISE General Counsel | -- | Direct | -- | May 1, 2023 |
HAHN MARK W Chief Financial Officer | Sale at price 20.72 per share. | Direct | 9,438,540 | May 1, 2023 |
ZACCARDELLI DAVID S Chief Executive Officer | Sale at price 20.72 per share. | Direct | 9,438,706 | May 1, 2023 |
POLL CLAIRE LOUISE General Counsel | Sale at price 20.72 per share. | Direct | 1,665,391 | May 1, 2023 |
POLL CLAIRE LOUISE General Counsel | Sale at price 20.72 per share. | Direct | 1,665,391 | May 1, 2023 |
RICKARD KATHLEEN A Officer | Sale at price 20.50 - 20.80 per share. | Direct | 2,460,584 | Feb 2, 2023 |
POLL CLAIRE LOUISE General Counsel | Sale at price 20.80 per share. | Indirect | 3,161,600 | Feb 1, 2023 |
POLL CLAIRE LOUISE General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 1, 2023 |
RICKARD KATHLEEN A Officer | -- | Direct | -- | Jan 20, 2023 |
POLL CLAIRE LOUISE General Counsel | -- | Direct | -- | Jan 20, 2023 |
GUPTA RISHI Director | Sale at price 21.71 - 24.11 per share. | Indirect | 136,000,855 | Dec 23, 2022 |
Related Tickers
MDGL Madrigal Pharmaceuticals, Inc.
343.81
+1.65%
RYTM Rhythm Pharmaceuticals, Inc.
64.10
+2.31%
APLS Apellis Pharmaceuticals, Inc.
28.50
-1.14%
TGTX TG Therapeutics, Inc.
27.66
+1.80%
RNA Avidity Biosciences, Inc.
47.33
+0.19%
BBIO BridgeBio Pharma, Inc.
25.77
+0.61%
IOVA Iovance Biotherapeutics, Inc.
12.30
+1.28%
ARDX Ardelyx, Inc.
6.27
-3.39%
ADMA ADMA Biologics, Inc.
19.98
+1.57%
JANX Janux Therapeutics, Inc.
55.73
+1.53%